These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30216151)

  • 1. Dupixent, a New Entrant In the Asthma Lists.
    Reinke T
    Manag Care; 2018 Sep; 27(9):14. PubMed ID: 30216151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dupilumab (Dupixent) for asthma.
    Med Lett Drugs Ther; 2019 Jan; 61(1563):6-8. PubMed ID: 30681662
    [No Abstract]   [Full Text] [Related]  

  • 3. Dupilumab: First Global Approval.
    Shirley M
    Drugs; 2017 Jul; 77(10):1115-1121. PubMed ID: 28547386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ▼Dupilumab for atopic dermatitis.
    Drug Ther Bull; 2018 Mar; 56(3):30-33. PubMed ID: 29545264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunobiologic treatments for severe asthma, atopic dermatitis, and chronic urticaria.
    Chiarella SE
    Allergy Asthma Proc; 2019 Nov; 40(6):485-489. PubMed ID: 31690400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of dupilumab in the treatment of atopic diseases.
    Thibodeaux Q; Smith MP; Ly K; Beck K; Liao W; Bhutani T
    Hum Vaccin Immunother; 2019; 15(9):2129-2139. PubMed ID: 30785362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benralizumab (Fasenra) for severe eosinophilic asthma.
    Med Lett Drugs Ther; 2018 Feb; 60(1541):33-35. PubMed ID: 29485975
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal Antibodies (Biologics) for Allergic Rhinitis, Asthma, and Atopic Dermatitis During Pregnancy and Lactation.
    L Ramos C; Namazy J
    Immunol Allergy Clin North Am; 2023 Feb; 43(1):187-197. PubMed ID: 36411004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupilumab for the treatment of asthma.
    Santini G; Mores N; Malerba M; Mondino C; Anzivino R; Macis G; Montuschi P
    Expert Opin Investig Drugs; 2017 Mar; 26(3):357-366. PubMed ID: 28085503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab (Dupixent) for moderate to severe atopic dermatitis.
    Med Lett Drugs Ther; 2017 Apr; 59(1519):64-66. PubMed ID: 28419072
    [No Abstract]   [Full Text] [Related]  

  • 11. Dupilumab for the treatment of asthma.
    Pelaia C; Vatrella A; Gallelli L; Terracciano R; Navalesi P; Maselli R; Pelaia G
    Expert Opin Biol Ther; 2017 Dec; 17(12):1565-1572. PubMed ID: 28990423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab for Moderate-to-Severe Atopic Dermatitis.
    Vangipuram R; Tyring SK
    Skin Therapy Lett; 2017 Nov; 22(6):1-4. PubMed ID: 29091379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
    Zimmermann M; Rind D; Chapman R; Kumar V; Kahn S; Carlson J
    J Drugs Dermatol; 2018 Jul; 17(7):750-756. PubMed ID: 30005097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab in the treatment of asthma.
    Grey A; Katelaris CH
    Immunotherapy; 2019 Jul; 11(10):859-872. PubMed ID: 31218914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis.
    Beck LA; Thaçi D; Hamilton JD; Graham NM; Bieber T; Rocklin R; Ming JE; Ren H; Kao R; Simpson E; Ardeleanu M; Weinstein SP; Pirozzi G; Guttman-Yassky E; Suárez-Fariñas M; Hager MD; Stahl N; Yancopoulos GD; Radin AR
    N Engl J Med; 2014 Jul; 371(2):130-9. PubMed ID: 25006719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies in severe asthma: is it worth it?
    Calzetta L; Matera MG; Rogliani P
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):517-520. PubMed ID: 31104515
    [No Abstract]   [Full Text] [Related]  

  • 18. Mapping knowledge structure and research of the biologic treatment of asthma: A bibliometric study.
    Sun J; Bai S; Zhao J; Li D; Ma X; Ma L; Su X
    Front Immunol; 2023; 14():1034755. PubMed ID: 36845128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologicals in the Treatment of Pediatric Atopic Diseases.
    Vom Hove M; Neininger MP; Bertsche T; Prenzel F
    Handb Exp Pharmacol; 2020; 261():131-151. PubMed ID: 32076895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab for the treatment of atopic dermatitis: A clinical trial review.
    McGregor S; Farhangian ME; Feldman SR
    Expert Opin Biol Ther; 2015; 15(11):1657-60. PubMed ID: 26428945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.